References
- Selivanova, G. (2004) P53: Fighting Cancer. Curr. Cancer. Drug Targets 4: 385-402. https://doi.org/10.2174/1568009043332934
- Horn, H. F. and K. H. Vousden (2007) Coping with stress: multiple ways to activate p53. Oncogene. 26: 1306-1316. https://doi.org/10.1038/sj.onc.1210263
- Molchadsky, A., N. Rivlin, R. Brosh, V. Rotter, and R. Sarig (2010) P53 is balancing development, differentiation and de-differentiation to assure cancer prevention. Carcinogenesis. 31: 1501-1508. https://doi.org/10.1093/carcin/bgq101
- Brosh, R. and V. Rotter (2009) When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer. 9: 701-713. https://doi.org/10.1038/nrc2693
- Walerych, D., M. Napoli, L. Collavin, and G. Del-Sal (2012) The rebel angel: mutant p53 as the driving oncogene in breast cancer. Carcinogenesis. 33: 2007-2017. https://doi.org/10.1093/carcin/bgs232
- Wijnhoven, S. W., E. N. Speksnijder, X. Liu, E. Zwart, C. T. van Oostrom, R. B. Beems, E. M. Hoogervorst, M. M. Schaap, L. D. Attardi, T. Jacks, H. van Steeg, J. Jonkers, and A. deVries (2007) Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage. Cancer Res. 67: 4648-4656. https://doi.org/10.1158/0008-5472.CAN-06-4681
- Mehta, S. A., K. W. Christopherson, P. Bhat-Nakshatri, J. R. Goulet-RJ, H. E. Broxmeyer, L. Kopelovich, and H. Nakshatri (2007) Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene. 26: 3329-3337. https://doi.org/10.1038/sj.onc.1210120
- Zhu, H. B., K. Yang, Y. Q. Xie, Y. W. Lin, Q. Q. Mao, and L. P. Xie (2013) Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells. World J. Surg. Oncol. 28: 11-22.
- Lim, L. Y., N. Vidnovic, L. W. Ellisen, and C. O. Leong (2009) Mutant p53 mediates survival of breast cancer cells. Br. J. Cancer. 101: 1606-1612. https://doi.org/10.1038/sj.bjc.6605335
- Bayraktar, S. and S. Gluck (2013) Molecularly targeted therapies for metastatic triple-negative breast cancer. Breast Cancer Res. Treat. 138: 21-35. https://doi.org/10.1007/s10549-013-2421-5
- Bae, Y. H., J. H. Ryu, H. J. Park, K. R. Kim, H. J. Wee, O. H. Lee, H. O. Jang, M. K. Bae, K. W. Kim, and S. K. Bae (2013) Mutant p53-notch1 signaling axis is involved in curcumin-induced apoptosis of breast cancer cells. Korean J. Physiol. Pharmacol. 17: 291-297. https://doi.org/10.4196/kjpp.2013.17.4.291
- Bae, Y. H., J. M. Shin, H. J. Park, H. O. Jang, M. K. Bae, and S. K. Bae (2014) Gain-of-function mutant p53-R280K mediates survival of breast cancer cells. Genes & Genomics 36: 171-178. https://doi.org/10.1007/s13258-013-0154-9